loading animation for AJAX calls

181 Reports in Pharmaceuticals

Antibody Drug Conjugates: Technologies and Global Markets

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM161B

The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.

The Chinese Market for Cancer Intervention

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM179A

The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a compound annual growth rate (CAGR) of 13.8% through 2022.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM026C

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Global Markets for Neglected Tropical Disease Treatments

Published - Jun 2017 | Publisher - BCC Publishing| Code - PHM180A

The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.

Drug Testing: Technologies and Global Markets

Published - May 2017 | Publisher - BCC Publishing| Code - PHM013G

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

Smart Pills: Applications and Global Markets

Published - May 2017 | Publisher - BCC Publishing| Code - PHM181A

The global market for smart pills reached $720 million in 2015. This market is expected to increase from $850 million in 2016 to $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 21.1% for 2016-2021. 

Cancer Immunology and Oncolytic Virology: Technologies and Global...

Published - May 2017 | Publisher - BCC Publishing| Code - PHM129B

The global cancer immunotherapy market should reach $96.5 billion by 2021 from $73.0 billion in 2016 at a compound annual growth rate (CAGR) of 5.7%, from 2016 to 2021.

Prevention and Treatment of Prostate Cancer: Technologies and Glo...

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM113B

The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in 2021, with a compound annual growth rate (CAGR) of 6.6%.

The Global Influenza Market

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM049D

The global influenza market reached $5.1 billion in 2015. This market is expected to increase from $5.4 billion in 2016 to $6.4 billion in 2021 at a compound annual growth rate (CAGR) of 3.6% for 2016-2021. 

Infectious Disease Drugs: The Chinese Market

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM178A

The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Mark...

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM050C

The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.

Antifungal Drugs: Technologies and Global Markets

Published - Mar 2017 | Publisher - BCC Publishing| Code - PHM029F

The global market for antifungal drugs was valued at $13.1 billion in 2016. The market should reach $16.1 billion by 2021, growing at a compound annual growth rate (CAGR) of 4.2% from 2016 to 2021.

Global Markets for Generic Drugs

Published - Feb 2017 | Publisher - BCC Publishing| Code - PHM009H

The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021.

Breakthrough Therapies: Market Dynamics and Investment Opportunit...

Published - Jan 2017 | Publisher - BCC Publishing| Code - PHM176A

The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.

Global Markets for Vaccine Technologies

Published - Jan 2017 | Publisher - BCC Publishing| Code - PHM014F

The global market for vaccine technologies reached $33.3 billion in 2016 and should reach $45.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2021.

Radiopharmaceuticals: Technologies and Global Markets

Published - Jan 2017 | Publisher - BCC Publishing| Code - PHM171B

The global market radiopharmaceuticals were valued at nearly $5.1 billion and $5.7 billion in 2014 and 2015, respectively. This market is expected to increase from nearly $6.5 billion in 2016 to $11.6 billion in 2021 at a compound annual growth rate (CAGR) of 12.4% for 2016-2021.

Cancer Vaccines: Technologies and Global Markets

Published - Nov 2016 | Publisher - BCC Publishing| Code - PHM173B

The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.

Gastrointestinal Therapeutics and Diagnostics: Technologies and G...

Published - Sep 2016 | Publisher - BCC Publishing| Code - PHM046C

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

Drugs and Diagnostics for Hematological Disorders: Global Markets

Published - Sep 2016 | Publisher - BCC Publishing| Code - PHM116B

The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020.

Antithrombotic/Anticoagulant Drugs: Technologies and Global Marke...

Published - Sep 2016 | Publisher - BCC Publishing| Code - PHM119B

The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016 at a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021.

Therapies for Rheumatoid Arthritis: Technologies and Global Marke...

Published - Jul 2016 | Publisher - BCC Publishing| Code - PHM072A

The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound annual growth rate (CAGR) of 1.3% from 2015 to 2020.

Excipients in Pharmaceuticals

Published - Mar 2016 | Publisher - BCC Publishing| Code - PHM010J

The global excipients market should reach nearly $6.9 billion by 2020 from approximately $6.3 billion in 2015, at a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Mar 2016 | Publisher - BCC Publishing| Code - PHM062C

The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.

Global Markets and Technologies for Advanced Drug Delivery System...

Published - Mar 2016 | Publisher - BCC Publishing| Code - PHM006K

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

Antibiotics: Technologies and Global Markets

Published - Mar 2016 | Publisher - BCC Publishing| Code - PHM025D

The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

« 1 2 3 4 5 »

1 Upcoming Reports in Pharmaceuticals

Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Target Date - Sep 2019| Publisher - BCC Publishing | Code - PHM220A| Price - $5,500
Report Includes
  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM